Public Health Expert Discusses Potential Impact of COVID-19 Pandemic on Access to Recommended First-Line Treatments for Chronic Pain

Newswise — An estimated 50 million adults in the United States suffer from chronic pain, including 20 million with high-impact pain that affects their work or lives most days or every day. Due to the COVID-19 pandemic, many more people are now struggling to manage their chronic pain.

Regents Professor John C. Licciardone is a board-certified physician in Public Health and Preventive Medicine and Director of the Pain Registry for Epidemiological, Clinical, and Interventional Studies and Innovation (PRECISION) at the University of North Texas Health Science Center. He discusses recent PRECISION research published in the Journal of Alternative and Complementary Medicine in light of the COVID-19 pandemic.

What are the common treatment options for people with chronic pain?

Clinical practice guidelines from such organizations as the Centers for Disease Control and Prevention (CDC) and the American College of Physicians (ACP) generally recommend starting with non-pharmacological treatments, and then progressing to drug treatment. Patients who have not adequately responded to these treatments may be considered candidates for opioids, if the potential benefit outweighs the risk.

Which treatments for chronic pain may be adversely impacted by the COVID-19 pandemic?

Our research published immediately prior to the COVID-19 pandemic found that non-pharmacological treatments were not being used by patients with chronic low back pain as often as recommended in the CDC and ACP guidelines. Common examples of these underutilized treatments that may be further impacted by the pandemic include massage therapy, spinal manipulation, yoga, and acupuncture. It will be interesting to see if this phenomenon results in greater reliance on drug treatment, including opioids, during the pandemic.

Are there patient subgroups that may be disproportionately affected during the pandemic and shutdowns?

Our research found that older Americans and African-Americans were least likely to use non-pharmacological treatments for chronic low back pain prior to the pandemic. Out-of-pocket costs for these treatments may be a possible explanation for this finding, as they are not universally covered by many health insurance plans, including Medicare and Medicaid.

Access to these non-pharmacological treatments will be further diminished during the pandemic and related shutdowns because treatment providers may not be available, or the treatments may require close personal contact that is not compatible with current social distancing guidelines.

How important are these non-pharmacological treatments in the overall management of chronic pain?

In our study, patients who had used at least one of these non-pharmacological treatments (massage therapy, spinal manipulation, yoga, or acupuncture) reported significantly lower levels of pain intensity and back-related disability than patients who had not used any of these treatments. Thus, they appear to be very important components in the management of chronic pain.

How is PRECISION functioning during the pandemic and shutdowns?

Fortunately, the impact of the pandemic has been minimal. Our registry uses digital technology to conduct all aspects of its research. People with chronic low back pain who live in the 48 contiguous states and the District of Columbia may screen to see if they qualify for the study. More information about the PRECISION Pain Research Registry may be found at


Filters close

Showing results

110 of 2869
Released: 11-Aug-2020 4:15 PM EDT
Medical Organizations Team Up to Help Parents and Caregivers Navigate Return to Sports and Recreation during COVID-19 Pandemic
American Medical Society for Sports Medicine (AMSSM)

The American Academy of Pediatrics (AAP), American Medical Society For Sports Medicine (AMSSM) and National Athletic Trainers’ Association (NATA) have joined forces to address growing concerns and confusion amid youth sports and recreation participation during the coronavirus pandemic.

Released: 11-Aug-2020 4:10 PM EDT
DHS to Hold Virtual Industry Day Seeking Innovative Solutions for Coronavirus Response
Homeland Security's Science And Technology Directorate

DHS S&T is seeking groundbreaking solutions to address current and future operational needs. S&T issued the Emerging Needs: Covid-19 Response & Future Mitigation topic call through its Silicon Valley Innovation Program (SVIP).

Newswise:Video Embedded bouncing-sticking-exploding-viruses-understanding-the-surface-chemistry-of-sars-cov-2
Released: 11-Aug-2020 3:45 PM EDT
Bouncing, Sticking, Exploding Viruses: Understanding the Surface Chemistry of SARS-CoV-2
Michigan Technological University

Better understanding of the surface chemistry of the SARS-CoV-2 virus is needed to reduce transmission and accelerate vaccine design.

Released: 11-Aug-2020 3:05 PM EDT
High Blood Sugar May Worsen COVID-19 Outcomes
Michigan Medicine - University of Michigan

Preliminary observations of COVID-19 patients with diabetes inspired an algorithm for glucose monitoring that’s suspected to help combat the virus’ serious complications.

Newswise:Video Embedded thriving-not-just-surviving
Released: 11-Aug-2020 2:15 PM EDT
Thriving, Not Just Surviving
The Electrochemical Society

In our series, The ECS Community Adapts and Advances, Alex Peroff spoke to us from his home office. Whereas travel used to be the largest part of his job, now he focuses on developing content and meaningful communication. Alex joined Pine Research Instrumentation, Inc. as an Electroanalytical Scientist in 2016 after completing a PhD at Northwestern University.

Released: 11-Aug-2020 1:55 PM EDT
COVID-19 clinical trials lack diversity
University of Georgia

Despite disproportionately higher rates of COVID-19 infection, hospitalization and death among people of color, minority groups are significantly underrepresented in COVID-19 clinical trials.

Newswise:Video Embedded adjusting-to-a-changed-world
Released: 11-Aug-2020 12:45 PM EDT
Adjusting to a Changed World
The Electrochemical Society

In our series, The ECS Community Adapts and Advances, Mark Orazem recounts how he made good use of a sabbatical year that didn’t turn out to be anything like he expected. Currently Professor of Chemical Engineering at the University of Florida (UF), he was officially on leave for the 2019-2020 academic year. He is returning to a very different environment than he left a year ago.

Showing results

110 of 2869